Skip to main content
Back to News
IQVIA has launched IQVIA.ai, a unified agentic AI platform built on NVIDIA’s Nemotron and NeMo toolk...
Partnership
1 min read

IQVIA has launched IQVIA.ai, a unified agentic AI platform built on NVIDIA’s Nemotron and NeMo toolk...

The AMW Read

IQVIA is a major vertical player updating its roadmap by deploying agentic systems specifically designed for the pharma value chain and clinical workflows.
NoveltySignificance
Healthcare & Bio · Player Map

IQVIA has launched IQVIA.ai, a unified agentic AI platform built on NVIDIA’s Nemotron and NeMo toolkits. The custom agents embed directly into clinical, commercial and real‑world workflows, promising faster trial start‑up, smarter data triage and higher decision speed for pharma partners. With 19 of the top 20 pharma companies already testing the agents, the rollout signals a new standard for AI‑driven drug development at scale.

How This Connects

Based on Healthcare & Bio · Player Map

  1. 1d agoSkyLabs Sets September KOSDAQ Listing, Discloses $18.4M H1 2026 Revenue and Otsuka Distribution DealSkyLabs
  2. 4d agoVivodyne, a biotech startup spun out of the University of Pennsylvania in 2021, has unveiled HIVE, a...Vivodyne
  3. 4d agoGenBio AI, a Palo Alto-based AI company co-founded by Nobel laureate David Baker, has released AIDO...GenBio AI
  4. 4mo agoIQVIA has launched IQVIA.ai, a unified agentic AI platform built on NVIDIA’s Nemotron and NeMo toolk... · THIS ARTICLE

More news from IQVIA

Stay updated with the latest news and announcements from IQVIA.

View all IQVIA news

Discover AI Startups

Explore 5,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard